Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Angiotensin-Converting-Enzyme Inhibitor”

269 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 269 results

Not applicableStudy completedNCT00321945
What this trial is testing

A Retrospective Analysis of the Use of ACE-inhibitors and Angiotensin Receptor Blockers

Who this might be right for
Atrial FibrillationAtrial Flutter
Emory University 546
Testing effectiveness (Phase 2)Looking for participantsNCT04183101
What this trial is testing

Evaluation of a Renin Inhibitor, Aliskiren, Compared to Enalapril, in C3 Glomerulopathy

Who this might be right for
C3 GlomerulopathyMembranoproliferative GlomerulonephritisComplement Abnormality+2 more
Region Skane 30
Not applicableStudy completedNCT01692795
What this trial is testing

Cardiovascular Medication Use Before First Myocardial Infarction

Who this might be right for
Myocardial Infarction
London School of Hygiene and Tropical Medicine 17,000
Large-scale testing (Phase 3)Study completedNCT00985322
What this trial is testing

Angiotensin-converting-enzyme (ACE) Inhibitors in Hemodialysis

Who this might be right for
Left Ventricular HypertrophyHypertension
Mario Negri Institute for Pharmacological Research 269
Post-approval studies (Phase 4)UnknownNCT00949351
What this trial is testing

Safety of Add on Aliskiren to Angiotensin Converting Enzyme Inhibitor (ACEI) and Angiotensin I Receptor Blocker (ARB) Treatment in Type 2 Diabetes With Nephropathy

Who this might be right for
Type 2 Diabetes With Nephropathy
Lerdsin General Hospital 80
Early research (Phase 1)UnknownNCT02623036
What this trial is testing

The Use of Ambulatory Blood Pressure Monitors to Assess Angiotensin Converting Enzyme Inhibitors

Who this might be right for
Hypertension, Resistant to Conventional Therapy
Memorial Health University Medical Center 20
Post-approval studies (Phase 4)Study completedNCT04353596
What this trial is testing

Stopping ACE-inhibitors in COVID-19

Who this might be right for
SARS-CoV-2COVID-19
Medical University Innsbruck 216
Post-approval studies (Phase 4)UnknownNCT00719316
What this trial is testing

Aliskiren and Muscle Sympathetic Nerve Activity

Who this might be right for
Chronic Kidney DiseaseHypertensionMuscle Sympathetic Nerve Activity
UMC Utrecht 30
Testing effectiveness (Phase 2)Study completedNCT01371747
What this trial is testing

Patiromer in the Treatment of Hyperkalemia in Patients With Hypertension and Diabetic Nephropathy (AMETHYST-DN)

Who this might be right for
Chronic Kidney DiseaseHypertensionHyperkalemia
Relypsa, Inc. 324
Post-approval studies (Phase 4)Study completedNCT01535235
What this trial is testing

ACE Inhibitors to Decrease Lymphoid Fibrosis in Antiretroviral-Treated, HIV-infected Patients: A Pilot Study

Who this might be right for
HIV
University of California, San Francisco 31
Post-approval studies (Phase 4)UnknownNCT00252317
What this trial is testing

Acute Haemodynamic Effects of Treatment With Angiotensin Converting Enzyme (ACE)-Inhibitors in Patients With Symptomatic Aortic Stenosis

Who this might be right for
Aortic Stenosis
Rigshospitalet, Denmark 64
Not applicableStudy completedNCT06096077
What this trial is testing

Evaluation of Tranexamic Acid for Angiotensin-converting Enzyme Inhibitor-induced Angioedema in the Emergency Department

Who this might be right for
Angioedema
Methodist Health System 50
Large-scale testing (Phase 3)Study completedNCT04881123
What this trial is testing

SER150 vs Placebo in Diabetic Kidney Disease

Who this might be right for
Diabetic Kidney Disease
Serodus AS 20
Post-approval studies (Phase 4)Looking for participantsNCT06704633
What this trial is testing

Sacubitril-valsartan in Patients With Heart Failure With Reduced Ejection Fraction From Rural Tanzania

Who this might be right for
Heart Failure
Martin Rohacek 298
Large-scale testing (Phase 3)Study completedNCT00437463
What this trial is testing

Treatment of Immunoglobulin A (IgA) Nephropathy by Angiotensin-Converting Enzyme (ACE) Inhibitor

Who this might be right for
Glomerulonephritis
Sanofi 60
Large-scale testing (Phase 3)Study completedNCT00355589
What this trial is testing

Ramipril and Hydrochlorothiazide Alone and in Combination for the Treatment of Essential Hypertension

Who this might be right for
HypertensionBlood Pressure, High
Pfizer
Testing effectiveness (Phase 2)UnknownNCT01036659
What this trial is testing

Evaluation of Ecallantide for the Acute Treatment of Angiotensin Converting Enzyme Inhibitor Induced Angioedema

Who this might be right for
Angioedema
Bernstein, Jonathan A., M.D. 50
Post-approval studies (Phase 4)Temporarily pausedNCT04330300
What this trial is testing

Coronavirus (COVID-19) ACEi/ARB Investigation

Who this might be right for
HypertensionCOVID-19
National University of Ireland, Galway, Ireland 2,414
Post-approval studies (Phase 4)UnknownNCT00235287
What this trial is testing

Pulse Wave Velocity, Pulse Wave Morphology and Blocking of the Reninangiotensin System in Patients With Chronic Kidney Disease

Who this might be right for
Kidney Failure, ChronicCardiovascular Diseases
Herlev Hospital 60
Not applicableEnded earlyNCT03121092
What this trial is testing

ACEI/ARB Study in Ambulatory and Day of Surgery Admission Patients

Who this might be right for
HypertensionHypotension
State University of New York - Downstate Medical Center 188
Next Page